Ripples of 2023: FBS’s Insight on the 2024 Global Financial Outlook
JOHANNESBURG, SOUTH AFRICA - Media OutReach Newswire - 18 December 2023 - With 2023 coming…
2 years ago
Azura Ophthalmics Announces Positive Results from Phase 2 Clinical Trial of AZR-MD-001 in Patients with Contact Lens Discomfort
Study met its primary endpoint and showed significant and clinically meaningful improvements in multiple symptoms…
2 years ago
AECOM joint venture appointed by Australia’s Sunwater as Engineering and Professional Services Partner
DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced that Sunwater has…
2 years ago
Chemours Works with Authorities in Northern China to Shutdown Chemical Plant Producing Fake Vitonâ„¢ FreeFlow
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--Law enforcement agencies in northern China have shut down large-scale manufacturing of counterfeit…
2 years ago
Vista Gold Corp. Announces Receipt of the $3 Million First Installment Payment Under Wheaton Precious Metals Royalty
DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista†or the “Companyâ€) is pleased…
2 years ago
Nippon Steel Corporation (NSC) to Acquire U. S. Steel, Moving Forward Together as the ‘Best Steelmaker with World-Leading Capabilities’
NSC to acquire U. S. Steel for $55.00 per share in an all-cash transaction representing…
2 years ago
NRI Secure Launches Security Assessment Service “AI Red Team,” for Systems Utilizing Generative AI
- Risk-based assessment for LLM and the entire system in two stages - TOKYO--(BUSINESS WIRE)--NRI…
2 years ago
Floki And TokenFi Launches Hong Kong Marketing Campaign Across 69 High-Definition Digital City Bus Screens
HONG KONG SAR - Media OutReach Newswire - 18 December 2023 - As part of…
2 years ago
HighField Biopharmaceuticals Doses First Patient in Phase 1 Trial of HFK1, a Unique Immunoliposome, for Treatment of HER2 low and HER2+ Cancers
The company’s groundbreaking drug encapsulated immunoliposomes may represent a significant improvement over existing antibody drug…
2 years ago
Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors
BEIJING & BARCELONA, Spain--(BUSINESS WIRE)--#ADC--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech…
2 years ago